Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.
Correlation of Parathyroid Hyperplasia by Ultrasound With Clinical and Laboratory Findings in Patients With Chronic Kidney Disease.
1 other identifier
observational
30
1 country
1
Brief Summary
Secondary hyperparathyroidism is an important complication in patient with chronic kidney disease . It is associated with bone complication and an increase in cardiovascular mortality The parathyroid hormone rises in these patients as consequence of low concentration of vitamin D3 ,reduction in quantities of serum calcium, phosphorus retention and reduction of vitamin D receptors sensitive to calcium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2017
CompletedFirst Posted
Study publicly available on registry
June 9, 2017
CompletedStudy Start
First participant enrolled
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedJune 27, 2018
June 1, 2018
6 months
June 8, 2017
June 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The percentage of patients with high parathyroid hormone level
laboratory measurement of parathyroid hormone
1 day
Study Arms (1)
chronic kidney diseases
patients with chronic renal failure on dialysis since 3-5 years
Eligibility Criteria
patients with chronic renal diseases
You may qualify if:
- stage 5 chronic renal failure
- dialysis (peritoneal ,or hemodialysis) since 3---5 years
You may not qualify if:
- previous of neck surgery.
- Patients refusal to participate in the study or voluntary withdrawal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut Faculty of Medicine
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Ahmed Abbas
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
June 8, 2017
First Posted
June 9, 2017
Study Start
February 1, 2018
Primary Completion
August 1, 2018
Study Completion
November 1, 2018
Last Updated
June 27, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share